Press Releases from DelveInsight Business Research (5777 total)
Spinal Cord Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, Spinal Cord Injury pipeline constitutes 35+ key companies continuously working towards developing 35+ Spinal Cord Injury treatment…
Tenosynovial Giant Cell Tumors Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Tenosynovial Giant Cell Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Tenosynovial Giant Cell…
Traumatic Brain Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury treatment therapies, analysis…
Ulcerative Colitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …
(Albany, USA) DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of…
Vitiligo Clinical Trials and Pipeline 2024: FDA Approvals, Medication, Treatment …
(Nevada, United States) As per DelveInsight's assessment, globally, Vitiligo pipeline constitutes 22+ key companies continuously working towards developing 22+ Vitiligo treatment therapies, analysis of Clinical…
Atopic Dermatitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 110+ Atopic Dermatitis treatment therapies, analysis…
Autosomal Dominant Polycystic Kidney Disease (AKPKD) Clinical Trials 2024: FDA A …
(Albany, United States) As per DelveInsight's assessment, globally, Autosomal Dominant Polycystic Kidney Disease pipeline constitutes 12+ key companies continuously working towards developing 12+ Autosomal Dominant…
Axillary Hyperhidrosis Clinical Trials 2024: FDA Approvals, Medication, Treatmen …
DelveInsight's, "Axillary Hyperhidrosis Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary Hyperhidrosis pipeline landscape. It covers the…
Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, Medication, Treatment …
(Albany, USA) DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape.…
Ewing Sarcoma Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, …
(Albany, USA) Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Exosomes Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Ther …
(Albany, USA) DelveInsight's 'Exosomes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline exosomes-based therapies in various stages of clinical development,…
Leptomeningeal Metastases Clinical Trials 2024: FDA Approvals, Medication, Treat …
(Albany, United States) As per DelveInsight's assessment, globally, Leptomeningeal Metastases pipeline constitutes 5+ key companies continuously working towards developing 5+ Leptomeningeal Metastases treatment therapies, analysis…
Liver Cirrhosis Clinical Trials 2024: FDA Approvals, Medication, Treatment Marke …
(Albany, USA) DelveInsight's, "Liver Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Liver Cirrhosis pipeline landscape. It…
Major Depressive Disorder Clinical Trials 2024: FDA Approvals, Medication, Treat …
(Albany, USA) DelveInsight's, "Major Depressive Disorder Pipeline Insight" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline…
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials 2024: FDA Approvals, Medicat …
(Albany, USA) DelveInsight's, "Paroxysmal Nocturnal Haemoglobinuria Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Paroxysmal Nocturnal Haemoglobinuria pipeline…
PCSK9 Inhibitors Clinical Trials 2024: FDA Approvals, Medication, Treatment Mark …
(Nevada, United States) As per DelveInsight's assessment, globally, PCSK9 Inhibitors pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitors treatment therapies, analysis…
PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: FDA Approvals, Medication, …
(Albany, USA) DelveInsight's 'PD-1 Non-Small Cell Lung Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline PD-1 non-small cell lung cancer therapies in…
Respiratory Syncytial Virus Clinical Trials 2024: FDA Approvals, Medication, Tre …
(Nevada, United States) As per DelveInsight's assessment, globally, Respiratory Syncytial Virus pipeline constitutes 50+ key companies continuously working towards developing 50+ Respiratory Syncytial Virus treatment…
Retinitis Pigmentosa Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, USA) DelveInsight's, "Retinitis Pigmentosa Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Retinitis Pigmentosa pipeline landscape. It…
Schizophrenia Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatm …
(Albany, USA) DelveInsight's 'Schizophrenia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Schizophrenia therapies in various stages of clinical development,…
Urothelial Carcinoma Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, United States) DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial…
Uveitis Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatment Ma …
(Nevada, United States) As per DelveInsight's assessment, globally, Uveitis pipeline constitutes 15+ key companies continuously working towards developing 15+ Uveitis treatment therapies, analysis of Clinical…
X-Linked Retinitis Pigmentosa Clinical Trials 2024: FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, the X-Linked Retinitis Pigmentosa Pipeline constitutes 5+ key companies continuously working towards developing 5+ X-Linked Retinitis Pigmentosa…
Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline The …
(Albany, United States) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Rosacea therapeutics…
Obsessive Compulsive Disorder Pipeline Analysis 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Obsessive Compulsive Disorder pipeline constitutes 5+ key companies continuously working towards developing 5+ Obsessive Compulsive…
ALK-positive Non-Small Cell Lung Cancer Clinical trials 2024: EMA, PDMA, FDA App …
DelveInsight's, "ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK-positive Non-Small…
Anorexia Nervosa Clinical trials 2024: EMA, PDMA, FDA Approvals, Medication, The …
As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Anorexia Nervosa therapeutics landscape based on…
Benign Breast Disease and Early Breast Cancer Drugs Market 2034: Clinical Trials …
(Albany, USA) DelveInsight's "Benign Breast Disease and Early Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Benign Breast…
Chronic Lymphocytic Leukemia Treatment Market 2034: Clinical Trials, EMA, PDMA, …
(Albany, USA) The Chronic Lymphocytic Leukemia market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
Janus Kinase (JAK) Inhibitors Pipeline Assessment 2024: EMA, PDMA, FDA Approvals …
(Albany, United States) As per DelveInsight's assessment, globally, Janus Kinase (JAK) Inhibitors pipeline constitutes key companies continuously working towards developing Janus Kinase (JAK) Inhibitors treatment…
Behcet's syndrome Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) The Behcet's syndrome market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment…
Tendinopathy Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, E …
(Albany, USA) The Tendinopathy market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options…
Synovial Sarcoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approval …
(Albany, USA) The Synovial Sarcoma market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment…
Stress urinary incontinence Treatment Market 2034: Clinical Trials, EMA, PDMA, F …
(Albany, USA) The Stress urinary incontinence market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
Thrombotic Thrombocytopenic Purpura Treatment Market 2034: Clinical Trials, EMA, …
(Albany, USA) The Thrombotic Thrombocytopenic Purpura market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging…
KRAS Inhibitors Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted epidemiology as well as…
HDAC Inhibitor Clinical Trials 2024 (Updated): EMA, PDMA, FDA Approvals, Clinica …
(Albany, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis…
Fabry Disease Market to grow at a CAGR of ~6% by 2032, analyzes DelveInsight | P …
(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well…
Secondary Hyperparathyroidism Drugs Market 2032: Clinical Trials, FDA Approvals, …
(Albany, USA) DelveInsight's "Secondary Hyperparathyroidism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Secondary Hyperparathyroidism, historical and forecasted epidemiology as well…
Atypical Hemolytic Uremic Syndrome Drugs Market 2034: Prevalence, FDA Approvals, …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and…
Epilepsy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Therapies, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical…
Alpha-1 Antitrypsin Deficiency Clinical Trials 2024: FDA Approvals, Medication, …
DelveInsight's, "Alpha1-Antitrypsin Deficiency Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha1-Antitrypsin Deficiency pipeline landscape. It covers…
Oral Mucositis Clinical Trials 2024: FDA Approvals, Medication, Treatment Market …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ Oral Mucositis companies continuously working towards developing 10+ Oral Mucositis Pipeline…
Constipation Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, …
(Albany, USA) DelveInsight's, "Constipation Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Constipation pipeline landscape. It covers…
Gastric Cancer Clinical Trials 2024: FDA Approvals, Medication, Treatment Market …
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the…
Colorectal Cancer Clinical Trials 2024: FDA Approvals, Medication, Treatment Mar …
(Albany, USA) DelveInsight's, "Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It…
CAR-T Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Therapi …
(Albany, USA) DelveInsight's, "CAR-T Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in CAR-T pipeline landscape. It covers the…
Ascites Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medica …
The market size of Ascites is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by…
Acute Lymphocytic Leukemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipel …
(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia…
HER2-Negative Breast Cancer Clinical Trials 2024: FDA Approvals, Companies, Medi …
(Albany, USA) DelveInsight's, "HER2-Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline…
